|
Attention Vytorin and Zetia Patients:
A proposed class-action lawsuit has been filed against Merck and Schering-Plough, manufacturers of Zetia and Vytorin alleging the companies violated state consumer protection laws arising from the sale and marketing of Zetia and Vytorin.
Vytorin is the combination of Zetia and Zocor, a statin now available as a generic drug for about one third of the cost.
The lawsuit centers around allegations that the companies have known since 2006 that the combination of drugs was no more effective than the generic version of Zocor in blocking the fatty arterial plaques that can cause heart attack and stroke, as it led consumers to believe.
The lawsuit seeks the return of money to purchasers of Vytorin and Zetia, which the study shows are no more effective than the generic form of Zocor.
If you are a Vytorin or Zetia patient and would like to join this lawsuit or simply get more information about this lawsuit, please contact the firm by sending an e-mail with your name, contact information, and circumstances to: info@galexwolf.com.
The following are recent news articles covering new developments in the effectiveness of Vytorin and Zetia:
January 15, 2008 - TIME
January 15, 2006 - Fox News
January 16, 2008 - Bloomberg
January 18, 2008 - CNN/Money
January 19, 2008 - The Home News Tribune
January 20, 2008 - The Star-Ledger
January 22, 2008 - MSN / AP
Note: Links to other sites, or links to this site by any other sites, do not imply any endorsement of, or relationship with, such other sites. |
|
|
